An item of here I thought might prove interesting:
Trastuzumab, Herceptin, should remain the standard of care for HER2-positive breast cancer, says a Mayo Clinic researcher, after analysis of more than 8,000 women with the cancer. These women participated in the world's largest study of two treatments for HER2-positive breast cancer. This study, being pre...Standard Care for HER2-Positive Breast Cancer: Trastuzumab
More on beauty advice
No comments:
Post a Comment